Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996
Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996
Use of Sumatriptan in Post-Ictal Migraine Headache
Neurol 47:1104, Jacob,J.,et al, 1996
A Double-Blind Study of Subcut Dihydroergotamine vs Subcut Sumatriptan in Treat of Acute Migraine
Arch Neurol 53:180-184, Winner,P.,et al, 1996
Long-term Prognosis in Cerebral Venous Thrombosis:Follow-up of 77 Patients
Stroke 27:243-246, Preter,M.,et al, 1996
Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996
Side Effect Profile of Interferon Beta-1b in MS:Results of an Open Label Trial
Neurol 46:552-554, Neilley,L.K.,et al, 1996
Stroke in Users of Low-Dose Oral Contraceptives
NEJM 335:8-15, 531996., Petitti,D.B.,et al, 1996
Ischaemic Stroke and Combined Oral Contraceptives:Results of an International, Multicentre, Case-Control Study
Lancet 348:498-505, Poulter,N.R.,et al, 1996
Bromocriptine and Postpartum Cerebral Angiopathy:A Causal Relationship
Neurol 46:1754-1756, Comabella,M.,et al, 1996
Cerebral Venous Sinus Thrombosis Associated with Factor V Gene Mutation
JNNP 61:204-205, Kimber,T.,et al, 1996
Antiepileptic Medication and Oral Contraceptive Interactions:A National Survey of Neurologists and Obstetricians
Neurol 46:1534-1539, Krauss,G.L.,et al, 1996
History of Migraine and Risk of Cerebral Ischaemia in Young Adults
Lancet 347:1503-1506, Carolei,A.,et al, 1996
Easy Therapeutical Management of Sumatriptan-Induced Daily Headache
Neurol 47:297-298, Gobel,H.,et al, 1996
Diagnosis and Management of Migraine
BMJ 312:1279-1283, Goadsby,P.J.&Olesen,J., 1996
A Comparison of Subcutaneous Sumatriptan and Dihydroergotamine Nasal Spray in the Acute Treatment of Migraine
Neurol 47:361-365, Touchon,J.,et al, 1996
Sumatriptan in Clinical Practice:A 2-year Review of 453 Migraine Patients
Neurol 47:46-51, Visser,W.H.,et al, 1996
Multicenter, Placebo-Controlled Trial of Cabergoline Taken Once Daily in the Treatment of Parkinson's Disease
Neurol 46:1062-1065, Hutton,J.T.,et al, 1996
Double-Blind Comparison of Cabergoline & Bromocriptine in Parkinson's Disease Pts with Motor Fluctuations
Neurol 47:785-788, Inzelberg,R.,et al, 1996
Medication for Children with Attentional Disorders
Pediatrics 98:301-304, Perrin,J.,et al, 1996
New Antiepileptic Drugs
NEJM 334:1583-1590, Dichter,M.A.&Brodie,M.J., 1996
Chiasmal Herniation as a Complication of Bromocriptine Therapy
J Neuro-Ophthalmol 16:252-257, Taxel,P.,et al, 1996
Rizatriptan vs Sumatriptan in Acute Trmt of Migraine. Dutch/US Rizatriptan Study Group
Arch Neurol 53:1132-1137, Visser,W.H.,et al, 1996
Retroperitoneal Fibrosis in a Patient with Parkinson's Disease Treated with Pergolide
Clin NeuroPharmacol 18:277-279, Jimenez-Jimenez,F.J.,et al, 1995
Image Analysis of B-Amyloid Load in Alzheimer's Disease and Relation to Dementia Severity
Lancet 346:1524-1528, Cummings,B.J.&Cotman,C.W., 1995
Apolipoprotein E, Dementia, and Cortical Deposition of B-Amyloid Protein
NEJM 333:1242-1247, 12831995., Polvikoski,T.,et al, 1995
Primary Prevention of Stroke
NEJM 333:1392-1400, Bronner,L.L.,et al, 1995
The Use of Sumatriptan in Patients with Monoamine Oxidase Inhibitors
Neurol 45:1039-1040, Diamond,S., 1995
Oral Sumatriptan in Prevent Headache Recurr after Trmt of Migraine with Subcut Sumatriptan
Neurol 45:1505-1509, Rappoport,A.M.,et al, 1995
Oral Sumatriptan for the Acute Treatment of Migraine:Eval of Three Dosage Strengths
Neurol 45:S5-S9, Cutler,N.,et al, 1995
Oral Sumatriptan is Effective & Well Tolerated for the Acute Trmt of Migraine:A Multictr Study
Neurol 45:S10-S14, S31995., Sargent,J.,et al, 1995
Oral Sumatriptan for the Long-Term Treatment of Migraine:Clinical Findings
Neurol 45:S15-S20, Rederich,G.,et al, 1995
Cardiac Arrest Following the Use of Sumatriptan
Neurol 45:1211-1213, Kelly,K.M., 1995
The Effect of Comb Oral Lysine Acetylsalicylate & Metoclopramide Compared w/Oral Sumatriptan for Migraine
Lancet 346:923-926, Tfelt-Hansen,P.,et al, 1995
Oral Sumatriptan-Associated Transmural Myocardial Infarction
Neurol 45:2274-2276, O'Connor,P.&Gladstone,P., 1995
Neuropathic Pain of Peripheral Origin:Advances in Pharmacologic Treatment
Neurol 45 (suppl 8) :s17-s25995., Galer,B.S., 1995
Severe Necrotizing Cutaneous Lesions Complicating Treatment with Interferon Beta-1b
NEJM 332:1584, Sheremata,W.A.,et al, 1995
Case-Control Study of Migraine and Risk of Ischaemic Stroke in Young Women
BMJ 310:830-833, Tzourio,C.,et al, 1995
Drug Treatment of Parkinson's Disease
BMJ 310:575-579, Quinn,N., 1995
Interferon Beta-1b in the Trtm of MS:Outcome of the Randomized Controlled Trial
IFNB Study Gr, Neurol 45:1277-12851995., , 1995
Effect of Interferon-B on Blood-Brain Barrier Disrupt Demonst by Contrast MRI in Relapsing-Remitting MS
Ann Neurol 37:611-619, Stone,L.A.,et al, 1995
The Impact of New Pharmaceutical Agents on the Cost of Neurologic Care
Neurol 45:569-572, Gunderson,C.H., 1995
Analgesic Headache
BMJ 310:479-480, Olesen,J., 1995
Postpartum Cerebral Angiopathy Possibly Due to Bromocriptine Therapy
Stroke 26:128-130, Janssens,E.,et al, 1995
The Interferons:Biological Effects, Mechanisms of Action, and Use in Multiple Sclerosis
Ann Neurol 37:7-15, Weinstock-Guttman,B.,et al, 1995
The Treatment of Attention-Deficit Hyperactivity Disorder in Tourette's Syndrome:A Study with Clonidine & Desipramine
Pediatrics 95:74-81, Singer,H.S.,et al, 1995
Is There a Problem with Long Term Use of Sumatriptan in Acute Migraine?
BMJ 308:113, Osborne,M.J.,et al, 1994
Clinical Exper from Sweden on Use of Subcutaneously Admin Sumatriptan in Migraine & Cluster Headache
Arch Neurol 51:1256-1261, Dahlof,C.,et al, 1994
Fluctuating Parkinson's Disease:Treatment with the Long-Acting Dopamine Agonist Cabergoline
Arch Neurol 51:1236-1241, Ahlskog,J.E.,et al, 1994
Betaseron for Multiple Sclerosis:Implications for Therapeutics
Arch Neurol 51:125-128, Rudick,R., 1994